MEDICARE FOUNDATN - UK C.I.C.

Company limited by guarantee

Company Registration Number:
15056342 (England and Wales)

Unaudited statutory accounts for the year ended 30 August 2024

Period of accounts

Start date: 8 August 2023

End date: 30 August 2024

MEDICARE FOUNDATN - UK C.I.C.

Contents of the Financial Statements

for the Period Ended 30 August 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

MEDICARE FOUNDATN - UK C.I.C.

Directors' report period ended 30 August 2024

The directors present their report with the financial statements of the company for the period ended 30 August 2024

Political and charitable donations

During the financial year the company did not take any political donations, neither did it make any financial contributions to any political party. Any charitable donations made were solely for the purpose of supporting non political charitable causes in alignment with the company's corporate social responsibilities.



Directors

The directors shown below have held office during the period of
11 August 2023 to 30 August 2024

Naana Hagan-Cherry
Abigail Tabiri


The director shown below has held office during the whole of the period from
8 August 2023 to 30 August 2024

Alexander Hagan-Cherry


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
28 January 2025

And signed on behalf of the board by:
Name: Naana Hagan-Cherry
Status: Director

MEDICARE FOUNDATN - UK C.I.C.

Profit And Loss Account

for the Period Ended 30 August 2024

13 months to 30 August 2024


£
Turnover: 16,001
Cost of sales: ( 8,922 )
Gross profit(or loss): 7,079
Administrative expenses: ( 11,943 )
Operating profit(or loss): (4,864)
Profit(or loss) before tax: (4,864)
Profit(or loss) for the financial year: (4,864)

MEDICARE FOUNDATN - UK C.I.C.

Balance sheet

As at 30 August 2024

Notes 13 months to 30 August 2024


£
Current assets
Cash at bank and in hand: 256
Total current assets: 256
Creditors: amounts falling due within one year: 3 ( 5,120 )
Net current assets (liabilities): (4,864)
Total assets less current liabilities: (4,864)
Total net assets (liabilities): (4,864)
Members' funds
Profit and loss account: (4,864)
Total members' funds: ( 4,864)

The notes form part of these financial statements

MEDICARE FOUNDATN - UK C.I.C.

Balance sheet statements

For the year ending 30 August 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 28 January 2025
and signed on behalf of the board by:

Name: Naana Hagan-Cherry
Status: Director

The notes form part of these financial statements

MEDICARE FOUNDATN - UK C.I.C.

Notes to the Financial Statements

for the Period Ended 30 August 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MEDICARE FOUNDATN - UK C.I.C.

Notes to the Financial Statements

for the Period Ended 30 August 2024

  • 2. Employees

    13 months to 30 August 2024
    Average number of employees during the period 0

MEDICARE FOUNDATN - UK C.I.C.

Notes to the Financial Statements

for the Period Ended 30 August 2024

3. Creditors: amounts falling due within one year note

13 months to 30 August 2024
£
Other creditors 5,120
Total 5,120

COMMUNITY INTEREST ANNUAL REPORT

MEDICARE FOUNDATN - UK C.I.C.

Company Number: 15056342 (England and Wales)

Year Ending: 30 August 2024

Company activities and impact

Throughout the financial year the company engaged in various community activities which presented various benefits; Educating and giving information associated with Sickle Cell diseases to support people with the disease and their families to cope with the disease. The company carried out various blood drives to help increase the NHS blood bank and recruiting new blood donors from the black community. Our campaigns, education, the awareness creation and all our activities educated the community and created the awareness that their actions (donating blood) will save lives, which in the end benefits the community. The community benefited from health-based activities and locally organised focused group carrying out various exercises to help with positive mental health. The company Created a space for socializing with the wider community, people and their families suffering the same condition and forging a sense of understanding and togetherness. Our Mentoring sessions helped to improve quality of life and improve mental health creating the awareness and importance of regular health checks which can help to discover certain diseases in their early stage and treated, helping to reduce sickness and diseases in the BAME. Community.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
28 January 2025

And signed on behalf of the board by:
Name: Naana Hagan-Cherry
Status: Director